BEVACIZUMAB
Clinical trials for BEVACIZUMAB explained in plain language.
Never miss a new study
Get alerted when new BEVACIZUMAB trials appear
Sign up with your email to follow new studies for BEVACIZUMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cancer drug ease heart strain in rare genetic disease?
Disease control ENROLLING_BY_INVITATIONThis study looks at whether the drug bevacizumab can help people with hereditary hemorrhagic telangiectasia (HHT) who have severe liver issues causing high heart output and possible heart failure. Researchers will track heart function before and after treatment in about 111 parti…
Matched conditions: BEVACIZUMAB
Sponsor: Poitiers University Hospital • Aim: Disease control
Last updated May 17, 2026 04:32 UTC
-
New drug cocktail aims to tackle Hard-to-Treat colorectal cancer
Disease control TerminatedThis study tested whether a combination of four drugs (BMS-986340, nivolumab, trifluridine/tipiracil, and bevacizumab) could help control advanced colorectal cancer that has stopped responding to standard treatments. It included 7 adults with a specific type of cancer called micr…
Matched conditions: BEVACIZUMAB
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 04:17 UTC